These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 25986886)
1. [Neuroendocrine neoplasms of the breast]. Anlauf M; Neumann M; Bomberg S; Luczak K; Heikaus S; Gustmann C; Antke C; Ezziddin S; Fottner C; Pavel M; Pape UF; Rinke A; Lahner H; Schott M; Cremer B; Hörsch D; Baum RP; Groh U; Alkatout I; Rudlowski C; Scheler P; Zirbes TK; Hoffmann J; Fehm T; Gabbert HE; Baldus SE Pathologe; 2015 May; 36(3):261-70. PubMed ID: 25986886 [TBL] [Abstract][Full Text] [Related]
2. [Spindle cell carcinoma of breast with neuroendocrine differentiation]. Ding HY; Gao LX Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):13-7. PubMed ID: 16608642 [TBL] [Abstract][Full Text] [Related]
3. Single institutional experience on primary neuroendocrine neoplasms of the kidney: a rare distinct entity. Amin M; Trikalinos N; Chatterjee D Hum Pathol; 2021 Aug; 114():36-43. PubMed ID: 33891968 [TBL] [Abstract][Full Text] [Related]
4. Nuclear Insulinoma-Associated Protein 1 Expression as a Marker of Neuroendocrine Differentiation in Neoplasms of the Breast. Seijnhaeve E; Galant C; Van Bockstal MR Int J Surg Pathol; 2021 Aug; 29(5):496-502. PubMed ID: 33426999 [TBL] [Abstract][Full Text] [Related]
5. Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumors. Möller K; Uhlig R; Gorbokon N; Dum D; Menz A; Büscheck F; Luebke AM; Hube-Magg C; Hinsch A; Höflmayer D; Fraune C; Lebok P; Weidemann S; Lennartz M; Jacobsen F; Clauditz TS; Steurer S; Burandt E; Krech R; Krech T; Marx AH; Sauter G; Simon R; Bernreuther C; Minner S Mol Cell Endocrinol; 2024 Feb; 581():112106. PubMed ID: 37951531 [TBL] [Abstract][Full Text] [Related]
6. Metastatic breast cancer simulating well-differentiated neuroendocrine neoplasms of visceral organs. Cloutier J; Thompson ED; Cimino-Mathews A; Rooper LM; Matoso A; Argani P Hum Pathol; 2018 Dec; 82():76-86. PubMed ID: 30031098 [TBL] [Abstract][Full Text] [Related]
7. The Clinical Significance of Neuroendocrine Features in Invasive Breast Carcinomas. Lai BS; Tsang JY; Poon IK; Shao Y; Chan SK; Tam FK; Cheung SY; Shea KH; Tse GM Oncologist; 2020 Sep; 25(9):e1318-e1329. PubMed ID: 32472950 [TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine differentiation correlates with hormone receptor expression and decreased survival in patients with invasive breast carcinoma. Kwon SY; Bae YK; Gu MJ; Choi JE; Kang SH; Lee SJ; Kim A; Jung HR; Kang SH; Oh HK; Park JY Histopathology; 2014 Apr; 64(5):647-59. PubMed ID: 24117859 [TBL] [Abstract][Full Text] [Related]
9. [Neuroendocrine tumors of the breast: Myth or reality? A systematic review]. Cheymol C; Abramovici O; Do Cao C; Dumont A; Robin YM; El Hajbi F; Dansin E; Bonneterre J; Lauridant G Bull Cancer; 2018 Apr; 105(4):431-439. PubMed ID: 29567279 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of neuroendocrine carcinoma of the breast. Sapino A; Papotti M; Righi L; Cassoni P; Chiusa L; Bussolati G Ann Oncol; 2001; 12 Suppl 2():S115-7. PubMed ID: 11762336 [TBL] [Abstract][Full Text] [Related]
12. INSM1 Expression in Breast Neoplasms with Neuroedocrine Features. Metovic J; Castellano I; Marinelli E; Osella-Abate S; Sapino A; Cassoni P; Papotti M Endocr Pathol; 2021 Dec; 32(4):452-460. PubMed ID: 34008122 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of the proliferative activity of neuroendocrine tumors from various organs. Are there indications for a neuroendocrine tumor-carcinoma sequence? Helpap B; Köllermann J Virchows Arch; 2001 Jan; 438(1):86-91. PubMed ID: 11213840 [TBL] [Abstract][Full Text] [Related]
14. Histopathological and Clinical Differences Between Primary Breast Carcinomas With Neuroendocrine Features and Primary Breast Carcinomas Mimicking Neuroendocrine Features. Kelten Talu C; Savli TC; Huq GE; Leblebici C Int J Surg Pathol; 2019 Oct; 27(7):744-752. PubMed ID: 31195855 [TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine neoplasms of the breast: a review of literature. Vegni F; De Stefano IS; Policardo F; Tralongo P; Feraco A; Carlino A; Ferraro G; Zhang Q; Scaglione G; D'Alessandris N; Navarra E; Zannoni G; Santoro A; Mule A; Rossi ED Virchows Arch; 2024 Aug; 485(2):197-212. PubMed ID: 38980337 [TBL] [Abstract][Full Text] [Related]
16. Primary breast carcinomas with neuroendocrine features: Clinicopathological features and analysis of tumor growth patterns in 36 cases. Kelten Talu C; Leblebici C; Kilicaslan Ozturk T; Hacihasanoglu E; Baykal Koca S; Gucin Z Ann Diagn Pathol; 2018 Jun; 34():122-130. PubMed ID: 29661717 [TBL] [Abstract][Full Text] [Related]
17. Breast cancer with neuroendocrine differentiation: an update based on the latest WHO classification. Tsang JY; Tse GM Mod Pathol; 2021 Jun; 34(6):1062-1073. PubMed ID: 33531618 [TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine Tumors of the Breast. Rosen LE; Gattuso P Arch Pathol Lab Med; 2017 Nov; 141(11):1577-1581. PubMed ID: 29072945 [TBL] [Abstract][Full Text] [Related]
19. Advances in the diagnosis and treatment of pancreatic neuroendocrine neoplasms in Japan. Ito T; Hijioka S; Masui T; Kasajima A; Nakamoto Y; Kobayashi N; Komoto I; Hijioka M; Lee L; Igarashi H; Jensen RT; Imamura M J Gastroenterol; 2017 Jan; 52(1):9-18. PubMed ID: 27539256 [TBL] [Abstract][Full Text] [Related]